Novel antipsychotics and acute dystonic reactions

Area of Science:

• Psychiatry
• Clinical Pharmacology

Background:

• Acute dystonic reactions (ADR) are a significant concern with antipsychotic use.
• The shift towards atypical antipsychotics may influence ADR prevalence.

Purpose of the Study:

• To determine the prevalence of acute dystonic reactions (ADR) in patients admitted to a psychiatric intensive care unit.
• To compare the incidence of ADR between typical and atypical antipsychotic medications.

Main Methods:

• A retrospective analysis of 1337 patients treated with antipsychotics in a psychiatric intensive care unit.
• Recording and categorizing all instances of acute dystonic reactions (ADR) during hospitalization.
• Comparing ADR rates across different antipsychotic classes, including typical neuroleptics, risperidone, olanzapine, quetiapine, sertindole, and clozapine.

Main Results:

• Overall, 41 cases (3.1%) experienced acute dystonic reactions (ADR) among 1337 antipsychotic-treated patients.
• A significantly higher incidence of ADR was observed with typical neuroleptics (32 cases) compared to atypical antipsychotics (5 cases).
• Atypical antipsychotics, including risperidone, olanzapine, and quetiapine, were associated with a minimal risk of ADR.

Conclusions:

• Atypical antipsychotics are associated with a significantly lower risk of acute dystonic reactions (ADR) compared to typical neuroleptics.
• The findings support the use of atypical antipsychotics to minimize the occurrence of ADR in psychiatric care settings.